Supernus Pharmaceuticals, Inc. (SUPN)
28.65
+0.30
(+1.06%)
USD |
NASDAQ |
Nov 20, 16:00
28.21
-0.44
(-1.54%)
After-Hours: 19:06
Supernus Pharmaceuticals Gross Profit (TTM) : 657.50M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 657.50M |
| June 30, 2026 | 629.69M |
| March 31, 2026 | 597.34M |
| December 31, 2025 | 552.85M |
| September 30, 2025 | 518.51M |
| June 30, 2025 | 508.22M |
| March 31, 2025 | 510.61M |
| December 31, 2024 | 503.52M |
| September 30, 2024 | 497.32M |
| June 30, 2024 | 471.72M |
| March 31, 2024 | 435.78M |
| December 31, 2023 | 438.90M |
| September 30, 2023 | 438.86M |
| June 30, 2023 | 456.14M |
| March 31, 2023 | 490.42M |
| December 31, 2022 | 493.92M |
| September 30, 2022 | 500.28M |
| June 30, 2022 | 494.35M |
| March 31, 2022 | 475.97M |
| December 31, 2021 | 472.12M |
| September 30, 2021 | 459.43M |
| June 30, 2021 | 462.60M |
| March 31, 2021 | 468.24M |
| December 31, 2020 | 449.20M |
| September 30, 2020 | 428.89M |
| Date | Value |
|---|---|
| June 30, 2020 | 399.28M |
| March 31, 2020 | 384.63M |
| December 31, 2019 | 376.10M |
| September 30, 2019 | 391.51M |
| June 30, 2019 | 392.98M |
| March 31, 2019 | 388.18M |
| December 31, 2018 | 393.54M |
| September 30, 2018 | 366.08M |
| June 30, 2018 | 341.24M |
| March 31, 2018 | 317.36M |
| December 31, 2017 | 284.83M |
| September 30, 2017 | 259.16M |
| June 30, 2017 | 238.58M |
| March 31, 2017 | 215.49M |
| December 31, 2016 | 203.02M |
| September 30, 2016 | 185.31M |
| June 30, 2016 | 168.26M |
| March 31, 2016 | 153.30M |
| December 31, 2015 | 138.27M |
| September 30, 2015 | 125.89M |
| June 30, 2015 | 140.72M |
| March 31, 2015 | 134.82M |
| December 31, 2014 | 116.29M |
| September 30, 2014 | 97.04M |
| June 30, 2014 | 46.89M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 553.08M |
| Prestige Consumer Healthcare, Inc. | 587.40M |
| Structure Therapeutics, Inc. | -4.741M |
| Corcept Therapeutics, Inc. | 949.55M |
| Veru, Inc. | -0.113M |